Navigation Links
Valeant to Acquire Dow Pharmaceutical Sciences, Inc. for $285 Million
Date:12/10/2008

($242 million net of cash). In the six month period following closing, Valeant will fund an escrow account of $35 million, which will be subject to indemnification claims from Valeant for a period of eighteen months following closing. The transaction is expected to be accretive in 2009. Additionally, Valeant will pay future milestones, based predominately on the achievement of approval and commercial targets for certain pipeline products still in development.

The transaction was approved by the boards of directors for both companies and is subject to customary closing conditions, including the expiration or early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvement Act of 1976, as amended. The transaction is expected to close at year end.

"This acquisition grows our scale and capabilities in dermatology thus solidifying Valeant's future as a leading company in the development and commercialization of dermatology medications," stated J. Michael Pearson, chairman and chief executive officer. "Gordon Dow, the founder of Dow Pharmaceutical Sciences, and his team are highly regarded with innovative formulation and development expertise, exemplified by having worked on ten dermatology approvals from the FDA in the past few years and with projects underway in eight of the top ten dermatology diagnoses. We are excited that they will be joining the Valeant team as we believe the synergies between our newly acquired Coria franchise and Dow's business will provide sustainable growth for many years to come."

Conference Call and Webcast and Presentation:

Valeant will host a conference call today at 11:00 a.m. EST (8:00 a.m. PST) to discuss the transaction. The dial-in number to participate on this call is (877) 295-5743, confirmation code 76913148. International callers should dial (973) 200-3961, confirmation code 76913148. A replay will be available approxim
'/>"/>

SOURCE Valeant Pharmaceuticals International
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. DFB Sells Coria Labs to Valeant Pharmaceuticals
2. Quantros Acquires MEDMARX(R) from United States Pharmacopeia (USP)
3. Azur Pharma Ltd. Enters Into Definitive Agreement With BioSante Pharmaceuticals Inc [nasdaq: BPAX], to Acquire U.S. Rights to Elestrin (TM)
4. Advanced Life Sciences Announces Cethromycin NDA Accepted for Filing by FDA for the Treatment of Community Acquired Pneumonia
5. Transgenomic Signs Letter of Intent for an Agreement to Exclusive License With Option to Acquire Power3 Medical Products Neurodegenerative Diagnostics
6. t2cure Acquires Patent Family on In Vitro Potency Testing of Stem Cells for Cardiovascular Application
7. Johnson & Johnson Announces Definitive Agreement to Acquire Omrix
8. BMP Sunstone Acquires Runchang Capsule and Related LFHC Technology
9. BBM Announces Offer to Acquire YM BioSciences Inc.
10. GlaxoSmithKline Commences Tender Offer to Acquire Genelabs Technologies, Inc.
11. Diagnostic Imaging - Enters Purchase Agreement to Acquire Teleradiology Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... when the transplant recipient,s immune system identifies the transplanted ... previously thought that T cells, the immune cells that ... as chemokines in order to migrate to the transplanted ... Clinical Investigation , Fadi Lakkis and colleagues at the ... stimulation of T cells is not required for migration. ...
(Date:5/17/2013)... 2013 - Elsevier, a world-leading provider of scientific, technical ... publication of a recent study in Reproductive ... showing that those with an abnormal chromosomal composition can ... developed to blastocysts, thereby classifying the risk of genetic ... same group has undertaken a retrospective study, using their ...
(Date:5/17/2013)... May 17, 2013 •    First of its ... for sustainability ,     New facility will help solve ... , Syngenta unveiled its new crop research ... company’s RTP Innovation Center. The first of its kind, ... simulate any agricultural climate and precisely measure plant inputs ...
(Date:5/17/2013)... 17, 2013  Cellular Biomedicine Group (OTCQB: CBMG) ... of the total projected enrollment required for its ... preliminary efficacy of the medical technology haMPC (Human ... (KOA). To date the trial has had no ... Phase I open label clinical research trial for ...
Breaking Biology Technology:Breakthrough for IVF? 2Breakthrough for IVF? 3Syngenta Opens Unique $72 Million Advanced Crop Lab 2Syngenta Opens Unique $72 Million Advanced Crop Lab 3Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis 2
... NEEDHAM, Mass., Feb. 24 Environment of Care ... tips to better achieve and maintain their organization,s ... of a new series of brief, web-based audio interviews ... free to play or download at http://www.eheinc.com/ec_bits.htm ...
... /PRNewswire-Asia-FirstCall/ -- China Sky One,Medical, Inc. ("China ... CSKI ), a,leading fully integrated ... Republic of China ("PRC"), today announced that ... Pharmaceutical Company ("Jin,Chuang"), signed an exclusive distribution ...
... 24 Eiger BioPharmaceuticals, Inc.,a start-up biotechnology company ... million in a Series A financing co-led by ... instrumental in the formation,of the company and recruitment ... board of,directors by general partners Nina Kjellson and ...
Cached Biology Technology:Web-based Audio Interviews Keep Environment of Care Managers Up-to-Date on Key EC Compliance Issues 2China Sky One Medical, Inc. Signs Exclusive Distribution Agreement with Shaanxi Buchang Group for Naftopidil Dispersible Tablets 2China Sky One Medical, Inc. Signs Exclusive Distribution Agreement with Shaanxi Buchang Group for Naftopidil Dispersible Tablets 3Eiger BioPharmaceuticals Raises $7.1 Million 'A' Round 2
(Date:5/16/2013)... the bone marrow in the liver, the spleen ... show that a specific type of immune cell facilitates ... hematopoiesis is essential for the function of the immune ... the liver and the spleen. Later the process is ... serves as the sole source of blood cells for ...
(Date:5/16/2013)... Ekwoge Enang Abwe, a conservationist working in Cameroon and ... program, has just been awarded the prestigious Whitley award. ... is often called "The Green Oscars" because it celebrates ... conservationists working in developing countries. Abwe was selected ... about and preserve Cameroon,s Ebo Forest and its wildlife ...
(Date:5/16/2013)... , May 16, 2013 ... Enhancement Award on Tuesday to Germany,s ... exceptional biometric border control system. DERMALOG has ... the Best Practices Award in the category Global Biometrics ... cutting edge Biometric   Border Control System . ...
Breaking Biology News(10 mins):Herpes infections: Natural killer cells activate hematopoiesis 2Cameroon researcher wins prestigious 'Green Oscar' 2Cameroon researcher wins prestigious 'Green Oscar' 3Global Biometrics and Border Control Award for DERMALOG 2Global Biometrics and Border Control Award for DERMALOG 3Global Biometrics and Border Control Award for DERMALOG 4
... within cells and increase a person,s susceptibility to bacterial ... new study published in Disease Models & Mechanisms ... bacteria Legionella , is facilitated by an increased ... mitochondrial disease. , Patients with mitochondrial disease exhibit a ...
... Brook, N.Y., July 27, 2009 - Temperature explains ... crustaceans, and lizards live longer at higher latitudes than ... in the Proceedings of the National Academy of ... Stephan Munch and Ph.D. candidate Santiago Salinas, both of ...
... Angeles, London, New Delhi, Singapore and Washington DC (July ... issue of Medical Decision Making , a large-scale, ... hospital resources even with an extremely effective public health ... attack and initiating a response to it. The ...
Cached Biology News:Stress signals link pre-existing sickness with susceptibility to bacterial infection 2Warmer environment means shorter lives for cold-blooded animals 2Bioterrorism and disaster preparedness explored in special issue of Medical Decision Making 2
... Simultaneously perform 96 assays on one plate. ... microarray plate with 96 (7mm x 7mm) ... gene expression, or screening analysis studies. Unlike ... fit gasket, eliminating the presence of contaminating ...
Bio-Plex Manager software, version 3.0, 5 license netshare, is a five-user software package that provides access to data from the Bio-Plex suspension array system from a server. This version does not...
... vapor-tight adhesive chambers for sealing hybridization reactions on ... a sample on a glass slide. Reaction solution ... the ports are then sealed with plastic sealing ... allow exchange of reaction fluid. These chambers enclose ...
... of integrins in vascular proliferation, adhesion, and ... family of cell adhesion receptors consists of ... an a and b subunit that associate ... functional diversity of the integrin family are ...
Biology Products: